Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
89.70
-8.80 (-8.93%)
At close: Apr 4, 2025, 4:00 PM
89.97
+0.27 (0.30%)
After-hours: Apr 4, 2025, 8:00 PM EDT
Boston Scientific Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 1,854 | 1,593 | 698 | 1,041 | -82 | Upgrade
|
| Depreciation & Amortization | 1,269 | 1,196 | 1,136 | 1,093 | 1,123 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 22 | -78 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 386 | 58 | 132 | 370 | 533 | Upgrade
|
| Loss (Gain) From Sale of Investments | 79 | 59 | 1 | -250 | -333 | Upgrade
|
| Stock-Based Compensation | 266 | 233 | 220 | 194 | 170 | Upgrade
|
| Other Operating Activities | 43 | 134 | 322 | -149 | 120 | Upgrade
|
| Change in Accounts Receivable | -351 | -238 | -220 | -279 | 335 | Upgrade
|
| Change in Inventory | -228 | -660 | -321 | -346 | -65 | Upgrade
|
| Change in Accounts Payable | 243 | 118 | -255 | 408 | -28 | Upgrade
|
| Change in Other Net Operating Assets | -126 | 10 | -209 | -134 | -265 | Upgrade
|
| Operating Cash Flow | 3,435 | 2,503 | 1,526 | 1,870 | 1,508 | Upgrade
|
| Operating Cash Flow Growth | 37.23% | 64.02% | -18.40% | 24.01% | -17.87% | Upgrade
|
| Capital Expenditures | -790 | -711 | -588 | -554 | -376 | Upgrade
|
| Sale of Property, Plant & Equipment | 3 | 4 | 12 | 14 | 12 | Upgrade
|
| Cash Acquisitions | -4,640 | -1,811 | -1,542 | -2,258 | -3 | Upgrade
|
| Divestitures | - | - | 5 | 826 | 15 | Upgrade
|
| Sale (Purchase) of Intangibles | 20 | 30 | 70 | 82 | 87 | Upgrade
|
| Investment in Securities | -280 | -89 | -24 | 279 | -146 | Upgrade
|
| Other Investing Activities | - | 3 | 56 | 14 | - | Upgrade
|
| Investing Cash Flow | -5,687 | -2,574 | -2,011 | -1,597 | -411 | Upgrade
|
| Short-Term Debt Issued | 211 | - | - | - | 4,161 | Upgrade
|
| Long-Term Debt Issued | 2,145 | - | 3,270 | - | 1,683 | Upgrade
|
| Total Debt Issued | 2,356 | - | 3,270 | - | 5,844 | Upgrade
|
| Short-Term Debt Repaid | -504 | -4 | -251 | - | -5,583 | Upgrade
|
| Long-Term Debt Repaid | -25 | - | -3,184 | - | -1,260 | Upgrade
|
| Total Debt Repaid | -529 | -4 | -3,435 | - | -6,843 | Upgrade
|
| Net Debt Issued (Repaid) | 1,827 | -4 | -165 | - | -999 | Upgrade
|
| Issuance of Common Stock | 230 | 182 | 136 | 110 | 1,086 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -535 | Upgrade
|
| Preferred Dividends Paid | - | -28 | -55 | -55 | -28 | Upgrade
|
| Dividends Paid | - | -28 | -55 | -55 | -28 | Upgrade
|
| Other Financing Activities | -243 | -145 | -464 | -150 | -206 | Upgrade
|
| Financing Cash Flow | 1,814 | 5 | -548 | -95 | 293 | Upgrade
|
| Foreign Exchange Rate Adjustments | -11 | -4 | -9 | -6 | -2 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -1 | - | - | 1 | - | Upgrade
|
| Net Cash Flow | -450 | -70 | -1,042 | 173 | 1,388 | Upgrade
|
| Free Cash Flow | 2,645 | 1,792 | 938 | 1,316 | 1,132 | Upgrade
|
| Free Cash Flow Growth | 47.60% | 91.05% | -28.72% | 16.25% | -17.67% | Upgrade
|
| Free Cash Flow Margin | 15.79% | 12.58% | 7.40% | 11.07% | 11.42% | Upgrade
|
| Free Cash Flow Per Share | 1.78 | 1.22 | 0.65 | 0.92 | 0.80 | Upgrade
|
| Cash Interest Paid | 250 | 259 | 450 | 338 | 359 | Upgrade
|
| Cash Income Tax Paid | 656 | 512 | 662 | 302 | 207 | Upgrade
|
| Levered Free Cash Flow | 1,808 | 1,880 | 1,155 | 2,654 | 1,110 | Upgrade
|
| Unlevered Free Cash Flow | 1,998 | 2,046 | 1,449 | 2,867 | 1,336 | Upgrade
|
| Change in Net Working Capital | 643 | 213 | 660 | -912 | 263 | Upgrade
|
Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.